Imperva (NYSE: IMPV) is one of 197 public companies in the “IT Services & Consulting” industry, but how does it contrast to its competitors? We will compare Imperva to similar businesses based on the strength of its valuation, dividends, analyst recommendations, profitability, earnings, institutional ownership and risk.

Risk and Volatility

Imperva has a beta of 2.23, suggesting that its stock price is 123% more volatile than the S&P 500. Comparatively, Imperva’s competitors have a beta of 1.26, suggesting that their average stock price is 26% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current recommendations for Imperva and its competitors, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Imperva 0 6 12 0 2.67
Imperva Competitors 1012 5159 7777 221 2.51

Imperva presently has a consensus price target of $52.57, suggesting a potential upside of 18.19%. As a group, “IT Services & Consulting” companies have a potential upside of 2.74%. Given Imperva’s stronger consensus rating and higher probable upside, research analysts clearly believe Imperva is more favorable than its competitors.

Insider and Institutional Ownership

92.7% of Imperva shares are held by institutional investors. Comparatively, 60.6% of shares of all “IT Services & Consulting” companies are held by institutional investors. 2.2% of Imperva shares are held by insiders. Comparatively, 17.2% of shares of all “IT Services & Consulting” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Imperva and its competitors revenue, earnings per share and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Imperva $293.55 million -$18.92 million -21.59
Imperva Competitors $2.12 billion $362.12 million 11.76

Imperva’s competitors have higher revenue and earnings than Imperva. Imperva is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.


This table compares Imperva and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Imperva -4.69% -5.00% -2.98%
Imperva Competitors -23.85% -65.07% -4.39%


Imperva beats its competitors on 8 of the 12 factors compared.

About Imperva

Imperva, Inc. provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services. Its Imperva SecureSphere provides database, file and Web application security across various physical and virtual systems in data centers, including in private, public and hybrid cloud computing environments. Its Imperva Incapsula product line provides cloud-based Website security, denial of service protection and performance solutions. Its Imperva Camouflage creates realistic, functional data for development, testing, and training by disguising sensitive information, while maintaining the characteristics of the original data.

Receive News & Stock Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related stocks with our FREE daily email newsletter.